Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Molecular pharmaceutics·2026
Same author

Preoperative Metabolic Predictors of Granulation Subtypes in Somatotroph Tumors: A Multicenter Retrospective Cohort Study.

CNS neuroscience & therapeutics·2026
Same author

Dynamic magneto-mechanical force in lysosomes induces durable macrophage repolarization for antitumor immunity.

Cell research·2026
Same author

Optimization of the Probiotic Fermentation Process of <i>Ganoderma lucidum</i> Juice and Its In Vitro Immune-Enhancing Potential.

Foods (Basel, Switzerland)·2026
Same author

Short-term exposure to ambient air pollution and hospital visits for Non-infectious diarrhea: A time-stratified case-crossover study in National Children's Regional Medical Center, Hefei, China, from 2015 to 2021.

Ecotoxicology and environmental safety·2026
Same author

DCBLD1 Promotes Lung Tumorigenesis by Inhibiting PTP1B Dephosphorylation of EGFR.

International journal of biological sciences·2026

Related Experiment Video

Updated: May 31, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Engineering polymeric aptamers for selective cytotoxicity.

Liu Yang1, Ling Meng, Xiaobing Zhang

  • 1Department of Chemistry, Shands Cancer Center, UF Genetics Institute, University of Florida, Gainesville, Florida 32611-7200, United States.

Journal of the American Chemical Society
|June 28, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces polymeric aptamers for targeted cancer therapy, reducing side effects and overcoming drug resistance by selectively killing cancer cells. This molecular engineering approach enhances drug delivery and design for improved chemotherapy outcomes.

More Related Videos

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
09:33

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor

Published on: March 21, 2018

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

Related Experiment Videos

Last Updated: May 31, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
09:33

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor

Published on: March 21, 2018

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

Area of Science:

  • Biotechnology
  • Molecular Engineering
  • Cancer Therapeutics

Background:

  • Conventional chemotherapy faces challenges including significant side effects and the development of drug resistance in cancer cells.
  • There is a critical need for novel therapeutic strategies that can selectively target cancer cells while minimizing harm to healthy tissues.

Purpose of the Study:

  • To develop a molecular engineering strategy using polymeric aptamers to induce selective cytotoxicity in target cancer cells.
  • To address limitations of current chemotherapy, including side effects and drug resistance, at the cellular level.

Main Methods:

  • Design and synthesis of polymeric aptamers composed of multiple cell-based aptamers and dye-labeled short DNA.
  • Exploitation of aptamer's target recognition for enhanced cell internalization via multivalent effects.
  • Incorporation of a cytotoxic polymer backbone within the conjugate, active only inside cells.

Main Results:

  • Polymeric aptamers demonstrated selective cytotoxicity in both normal cancer cells and drug-resistant cells.
  • Enhanced cell internalization was observed due to multivalent effects of the polymeric structure.
  • Control assays confirmed the nontoxicity of the aptamer alone, with cytotoxicity attributed to the polymer backbone's properties within the cell.

Conclusions:

  • The developed polymeric aptamer strategy offers a promising approach for selective cancer cell killing, overcoming drug resistance.
  • This molecular engineering method enhances drug delivery and design, potentially leading to improved chemotherapy outcomes with reduced side effects.
  • The findings suggest a new paradigm for developing targeted cancer therapeutics with inherent cytotoxic mechanisms activated intracellularly.